BioNexus Gene Lab (BGLC) Change in Receivables (2022 - 2026)
BioNexus Gene Lab (BGLC) reported Change in Receivables of -$243016.0 for Q1 2026, down 315.79% on a YoY basis from $112615.0 in Q1 2025, and up 74.28% sequentially from -$944701.0 in Q4 2025.
BioNexus Gene Lab (BGLC) Change in Receivables (2022 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 5 years of Change in Receivables data on file, last reported at -$243016.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 315.79% year-over-year to -$243016.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (down 1572.26% YoY), and the FY2025 full-year result was -$782841.0, down 429.81% from the prior year.
- Change in Receivables improved to -$243016.0 in Q1 2026, from -$944701.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.2 million in Q4 2023 to a low of -$944701.0 in Q4 2025.
- A 5-year average of -$72575.5 and a median of -$131925.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables jumped 713.03% in 2024 and plunged 32924.91% in 2025, its largest moves.
- Tracing BGLC's Change in Receivables over 5 years: stood at -$112236.0 in 2022, then surged by 1130.4% to $1.2 million in 2023, then sank by 99.75% to $2878.0 in 2024, then sank by 32924.91% to -$944701.0 in 2025, then jumped by 74.28% to -$243016.0 in 2026.
- Business Quant data shows BGLC's Change in Receivables at -$243016.0 in Q1 2026, -$944701.0 in Q4 2025, and -$206475.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 361.00 Mn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | - |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | 35.60 Mn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | 23.60 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | 343.00 Mn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | 797.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | - |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 107.00 Mn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | -23.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | -243,016.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -243,016.00 |
| Mar 31, 2026 | -243,016.00 |
| Dec 31, 2025 | -944,701.00 |
| Dec 31, 2025 | -944,701.00 |
| Sep 30, 2025 | -206,475.00 |
| Sep 30, 2025 | -206,475.00 |
| Jun 30, 2025 | 255,720.00 |
| Jun 30, 2025 | 255,720.00 |
| Mar 31, 2025 | 112,615.00 |
| Mar 31, 2025 | 112,615.00 |
| Dec 31, 2024 | 2,878.00 |
| Dec 31, 2024 | 2,878.00 |
| Sep 30, 2024 | -153,279.00 |
| Sep 30, 2024 | -153,279.00 |
| Jun 30, 2024 | 115,114.00 |
| Jun 30, 2024 | 115,114.00 |
| Mar 31, 2024 | -112,473.00 |
| Mar 31, 2024 | -112,473.00 |
| Dec 31, 2023 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |